Search Results - "Washam, Jeffrey B"

Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association by van Diepen, Sean, Katz, Jason N, Albert, Nancy M, Henry, Timothy D, Jacobs, Alice K, Kapur, Navin K, Kilic, Ahmet, Menon, Venu, Ohman, E Magnus, Sweitzer, Nancy K, Thiele, Holger, Washam, Jeffrey B, Cohen, Mauricio G

“…Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state of end-organ hypoperfusion that is frequently associated with…”
Get full text

Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association by Raval, Amish N, Cigarroa, Joaquin E, Chung, Mina K, Diaz-Sandoval, Larry J, Diercks, Deborah, Piccini, Jonathan P, Jung, Hee Soo, Washam, Jeffrey B, Welch, Babu G, Zazulia, Allyson R, Collins, Sean P

“…Non–vitamin K oral anticoagulants (NOACs) are now widely used as alternatives to warfarin for stroke prevention in atrial fibrillation and management of venous…”
Get full text

Perioperative Beta Blockade in Noncardiac Surgery: A Systematic Review for the 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery by Wijeysundera, Duminda N., MD, PhD, Duncan, Dallas, MD, MHSc, Nkonde-Price, Chileshe, MD, MS, Virani, Salim S., MD, PhD, FACC, FAHA, Washam, Jeffrey B., PharmD, FAHA, Fleischmann, Kirsten E., MD, MPH, FACC, Fleisher, Lee A., MD, FACC, FAHA

“…Objective To review the literature systematically to determine whether initiation of beta blockade within 45 days prior to noncardiac surgery reduces 30-day…”
Get full text

The Genesis, Maturation, and Future of Critical Care Cardiology by Katz, Jason N., MD, MHS, Minder, Michael, MD, Olenchock, Benjamin, MD, PhD, Price, Susanna, MD, PhD, Goldfarb, Michael, MD, Washam, Jeffrey B., PharmD, Barnett, Christopher F., MD, MPH, Newby, L. Kristin, MD, van Diepen, Sean, MD, MSc

“…Abstract The cardiac intensive care unit (CICU) has changed considerably over time and now serves a unique patient population with a high burden of…”
Get full text

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) by Washam, Jeffrey B, Pharm D, Stevens, Susanna R, MS, Lokhnygina, Yuliya, PhD, Halperin, Jonathan L, Prof, Breithardt, Günter, Prof, Singer, Daniel E, Prof, Mahaffey, Kenneth W, Prof, Hankey, Graeme J, Prof, Berkowitz, Scott D, MD, Nessel, Christopher C, MD, Fox, Keith A A, Prof, Califf, Robert M, Prof, Piccini, Jonathan P, MD, Patel, Manesh R, Dr

“…Summary Background Digoxin is a widely used drug for ventricular rate control in patients with atrial fibrillation (AF), despite a scarcity of randomised trial…”
Get full text

Comparative Efficacy of Dronedarone and Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation by Piccini, Jonathan P., MD, MHS, Hasselblad, Vic, PhD, Peterson, Eric D., MD, MPH, Washam, Jeffrey B., PharmD, Califf, Robert M., MD, Kong, David F., MD

“…Objectives We sought to compare the efficacy and safety of dronedarone versus amiodarone for the prevention of recurrent atrial fibrillation (AF). Background…”
Get full text

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial) by Washam, Jeffrey B., Hellkamp, Anne S., Lokhnygina, Yuliya, Piccini, Jonathan P., Berkowitz, Scott D., Nessel, Christopher C., Becker, Richard C., Breithardt, Günter, Fox, Keith A.A., Halperin, Jonathan L., Hankey, Graeme J., Mahaffey, Kenneth W., Singer, Daniel E., Patel, Manesh R.

“…Non-dihydropyridine calcium channel blockers (non-DHP CCBs) possess combined P-glycoprotein and moderate CYP3A4 inhibition, which may lead to increased…”
Get full text

Characteristics, Management, and Outcomes of Cocaine-Positive Patients With Acute Coronary Syndrome (from the National Cardiovascular Data Registry) by Gupta, Navdeep, MD, Washam, Jeffrey B., PharmD, Mountantonakis, Stavros E., MD, Li, Shuang, MS, Roe, Matthew T., MD, MHS, de Lemos, James A., MD, Arora, Rohit, MD

“…Although cocaine ingestion may cause or contribute to myocardial infarction (MI), few contemporary data are available describing cocaine-associated MI. We…”
Get full text

Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry by Rymer, Jennifer A, Bhatt, Deepak L, Angiolillo, Dominick J, Diaz, Miguel, Garratt, Kirk N, Waksman, Ron, Edwards, Laura, Tasissa, Gudaye, Salahuddin, Khalid, El-Sabae, Hijrah, Dell'Anna, Carmen, Davidson-Ray, Linda, Washam, Jeffrey B, Ohman, E Magnus, Wang, Tracy Y

“…Background In clinical trials, cangrelor has been shown to reduce percutaneous coronary intervention–related ischemic complications without increasing major…”
Get full text

The Prevention of Critical Care Complications in Coronary Intensive Care Unit: Protocols, Bundles, and Insights from Intensive Care Studies by van Diepen, Sean, MD MSc, Sligl, Wendy I., MD MSc, Washam, Jeffrey B., PhamD, Gilchrist, Ian C., MD, Arora, Rakesh C., MD, PhD, Katz, Jason N., MD, MHS

“…Unstructured Abstract Over the last half century coronary care units have expanded from specialized ischemia arrhythmia monitoring units into intensive care…”
Get full text

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF by Washam, Jeffrey B, Holmes, DaJuanicia N, Thomas, Laine E, Pokorney, Sean D, Hylek, Elaine M, Fonarow, Gregg C, Mahaffey, Kenneth W, Gersh, Bernard J, Kowey, Peter R, Ansell, Jack E, Go, Alan S, Reiffel, James A, Freeman, James V, Singer, Daniel E, Naccarelli, Gerald, Blanco, Rosalia, Peterson, Eric D, Piccini, Jonathan P

“…Background Chronic kidney disease ( CKD ) is a common comorbidity in patients with atrial fibrillation. The presence of CKD complicates drug selection for…”
Get full text

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies by Steinberg, Benjamin A., Hasselblad, Vic, Atwater, Brett D., Bahnson, Tristram D., Washam, Jeffrey B., Alexander, John H., Daubert, James P., Piccini, Jonathan P.

“…Purpose Dabigatran is approved for prevention of stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF). The safety and…”
Get full text

Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial by Pokorney, Sean D., Chertow, Glenn M., Al-Khalidi, Hussein R., Gallup, Dianne, Dignacco, Pat, Mussina, Kurt, Bansal, Nisha, Gadegbeku, Crystal A., Garcia, David A., Garonzik, Samira, Lopes, Renato D., Mahaffey, Kenneth W., Matsuda, Kelly, Middleton, John P., Rymer, Jennifer A., Sands, George H., Thadhani, Ravi, Thomas, Kevin L., Washam, Jeffrey B., Winkelmayer, Wolfgang C., Granger, Christopher B.

“…There are no randomized data evaluating the safety or efficacy of apixaban for stroke prevention in patients with end-stage kidney disease on hemodialysis and…”
Get full text

When cardiovascular medicines should be discontinued by Krychtiuk, Konstantin A, Gersh, Bernard J, Washam, Jeffrey B, Granger, Christopher B

“…An integral component of the practice of medicine is focused on the initiation of medications, based on clinical practice guidelines and underlying trial…”
Get full text

Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines by Wijeysundera, Duminda N, Duncan, Dallas, Nkonde-Price, Chileshe, Virani, Salim S, Washam, Jeffrey B, Fleischmann, Kirsten E, Fleisher, Lee A

“…To review the literature systematically to determine whether initiation of beta blockade within 45 days prior to noncardiac surgery reduces 30-day…”
Get full text

Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention by Sherwood, Matthew W., MD, MHS, Cyr, Derek D., PhD, Jones, W. Schuyler, MD, Becker, Richard C., MD, Berkowitz, Scott D., MD, Washam, Jeffrey B., PharmD, Breithardt, Günter, MD, Fox, Keith A.A., MB, ChB, Halperin, Jonathan L., MD, Hankey, Graeme J., MD, Singer, Daniel E., MD, Piccini, Jonathan P., MD, MHS, Nessel, Christopher C., MD, Mahaffey, Kenneth W., MD, Patel, Manesh R., MD

“…Abstract Objectives The authors assessed the use of dual antiplatelet therapy (DAPT) and outcomes in patients undergoing percutaneous coronary intervention…”
Get full text

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial by Jaspers Focks, Jeroen, Brouwer, Marc A, Wojdyla, Daniel M, Thomas, Laine, Lopes, Renato D, Washam, Jeffrey B, Lanas, Fernando, Xavier, Denis, Husted, Steen, Wallentin, Lars, Alexander, John H, Granger, Christopher B, Verheugt, Freek W A

“…Objective To determine whether the treatment effect of apixaban versus warfarin differs with increasing numbers of concomitant drugs used by patients with…”
Get full text

Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation by Piccini, Jonathan P, Hellkamp, Anne S, Washam, Jeffrey B, Becker, Richard C, Breithardt, Günter, Berkowitz, Scott D, Halperin, Jonathan L, Hankey, Graeme J, Hacke, Werner, Mahaffey, Kenneth W, Nessel, Christopher C, Singer, Daniel E, Fox, Keith A.A, Patel, Manesh R

“…BACKGROUND—Patients with atrial fibrillation (AF) often take multiple medications. METHODS AND RESULTS—We examined characteristics and compared adjusted…”
Get full text

Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart Association by Fordyce, Christopher B., Katz, Jason N., Alviar, Carlos L., Arslanian-Engoren, Cynthia, Bohula, Erin A., Geller, Bram J., Hollenberg, Steven M., Jentzer, Jacob C., Sims, Daniel B., Washam, Jeffrey B., van Diepen, Sean

“…Contemporary cardiac intensive care units (CICUs) have an increasing prevalence of noncardiovascular comorbidities and multisystem organ dysfunction. However,…”
Get full text

Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week by Sullivan, Alexander E, Nanna, Michael G, Wang, Tracy Y, Bhatt, Deepak L, Angiolillo, Dominick J, Mehran, Roxana, Banerjee, Subhash, Cantrell, Sarah, Jones, W Schuyler, Rymer, Jennifer A, Washam, Jeffrey B, Rao, Sunil V, Ohman, E Magnus

“…Patients undergoing early surgery after coronary stent implantation are at increased risk for mortality from ischemic and hemorrhagic complications. The…”
Get full text